BioWorld-International-2005-01-05
Neuro3d's Third Round: EUR31.5M For Development Of Lead Drugs
Neuro3d's Third Round: EUR31.5M For Development Of Lead Drugs
PARIS - Neuro3d closed a third round of financing in which it raised 31.5 million (US$41.6 million) from eight European venture capital funds. (BioWorld International)

